Home/Filings/4/0000950170-25-090141
4//SEC Filing

Foote Marion R 4

Accession 0000950170-25-090141

CIK 0001445283other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 9:52 PM ET

Size

10.5 KB

Accession

0000950170-25-090141

Insider Transaction Report

Form 4
Period: 2025-06-23
Transactions
  • Exercise/Conversion

    Common Stock

    2025-06-23$0.61/sh+12,500$7,638163,862 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-06-2312,5000 total
    Exercise: $0.61Exp: 2034-09-03Common Stock (12,500 underlying)
  • Tax Payment

    Common Stock

    2025-06-23$0.26/sh4,706$1,224159,156 total
  • Award

    Common Stock

    2025-06-25+6,000165,156 total
Footnotes (1)
  • [F1]Pursuant to the terms of (i) the Optionholder Treatment Agreement, dated June 16, 2025, by and between Kineta, Inc. (the "Company") and the Reporting Person, and (ii) the Agreement and Plan of Merger, dated as of December 11, 2024, by and among the Company, TuHURA Biosciences, Inc., a Nevada corporation ("TuHURA"), Hura Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of TuHURA, Hura Merger Sub II, a Delaware limited liability company and a wholly owned subsidiary of TuHURA, and Craig Philips, as representative of the stockholders of the Company, and as amended by that certain First Amendment to Agreement and Plan of Merger, dated May 5, 2025, as approved by the Company's stockholders at the Special Meeting of Stockholders held on June 23, 2025, the options granted to the Reporting Person under the 2022 Equity Incentive Plan became fully vested on June 23, 2025.

Documents

1 file

Issuer

KINETA, INC./DE

CIK 0001445283

Entity typeother

Related Parties

1
  • filerCIK 0001490837

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 9:52 PM ET
Size
10.5 KB